Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Description
N/A
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.0 - 0.0
Trade Value (12mth)
N/A
1 week
14%
1 month
1.79%
YTD
171.43%
1 year
9.62%
All time high
N/A
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Shares on Issue (Fully Dilluted)
N/A
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
N/A
Short Sell (% of issue)
N/A
Date | Announcements |
---|---|
16 July 24 |
GLP Studies Update
×
GLP Studies Update |
09 July 24 |
Nyrada Quarterly Activities Report & Appendix 4C
×
Nyrada Quarterly Activities Report & Appendix 4C |
01 July 24 |
Notification of cessation of securities - NYR
×
Notification of cessation of securities - NYR |
26 June 24 |
NYR Signs Strategic Partnership with US Brain Injury Company
×
NYR Signs Strategic Partnership with US Brain Injury Company |
12 June 24 |
Application for quotation of securities - NYR
×
Application for quotation of securities - NYR |
12 June 24 |
Cleansing Statement
×
Cleansing Statement |
12 June 24 |
Notification regarding unquoted securities - NYR
×
Notification regarding unquoted securities - NYR |
12 June 24 |
Change of Director's Interest Notice - ID
×
Change of Director's Interest Notice - ID |
12 June 24 |
Change of Director's Interest Notice - RW
×
Change of Director's Interest Notice - RW |
12 June 24 |
Change of Director's Interest Notice - MF
×
Change of Director's Interest Notice - MF |
12 June 24 |
Change of Director's Interest Notice - JM
×
Change of Director's Interest Notice - JM |
27 May 24 |
Upcoming Expiry of Unlisted Warrants
×
Upcoming Expiry of Unlisted Warrants |
16 May 24 |
Nyrada General Meeting Results
×
Nyrada General Meeting Results |
30 April 24 |
Nyrada Commences Walter Reed Traumatic Brain Injury Study
×
Nyrada Commences Walter Reed Traumatic Brain Injury Study |
18 April 24 |
Investor Presentation - April 2024
×
Investor Presentation - April 2024 |
11 April 24 |
3QFY2024 Results and Investor Conference Call
×
3QFY2024 Results and Investor Conference Call |
10 April 24 |
Quarterly Activities Report and Appendix 4C
×
Quarterly Activities Report and Appendix 4C |
02 April 24 |
2024 EGM Notice of Meeting and Proxy
×
2024 EGM Notice of Meeting and Proxy |
02 April 24 |
2024 EGM Letter to Shareholders and Proxy
×
2024 EGM Letter to Shareholders and Proxy |
28 March 24 |
Nyrada Commences Key Brain Injury Program Preclinical Study
×
Nyrada Commences Key Brain Injury Program Preclinical Study |
15 March 24 |
Amended and Restated Certificate of Incorporation and Bylaw
×
Amended and Restated Certificate of Incorporation and Bylaw |
15 March 24 |
Application for quotation of securities - NYR
×
Application for quotation of securities - NYR |
15 March 24 |
Cleansing Statement
×
Cleansing Statement |
15 March 24 |
Notice of Change of Interests of Substantial Securityholder
×
Notice of Change of Interests of Substantial Securityholder |
15 March 24 |
Notice of Change of Interests of Substantial Securityholder
×
Notice of Change of Interests of Substantial Securityholder |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.